<--- Back to Details
First PageDocument Content
Health economics / B-cell chronic lymphocytic leukemia / Lymphocytic leukemia / Lymphoma / Orphan drugs / Leukemia / Chlorambucil / End point of clinical trials / Rituximab / Medicine / Oncology / Health
Date: 2015-04-22 23:39:46
Health economics
B-cell chronic lymphocytic leukemia
Lymphocytic leukemia
Lymphoma
Orphan drugs
Leukemia
Chlorambucil
End point of clinical trials
Rituximab
Medicine
Oncology
Health

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 216,60 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1wJbG - View Document

PDF Document

DocID: 1wqI7 - View Document

Worker Sorting, Taxes and Health Insurance Coverage1 Kevin Lang Boston University and NBER & IZA Dept. of Economics Boston University 270 Bay State Road

DocID: 1vkT8 - View Document

Information on pharmaceutical product quality and physician adoption Katharina Elisabeth Fischer*a,b, Kay Petersa,c and Tom Stargardta a CINCH Health Economics Research Center and Faculty of Business Administration a

DocID: 1vdXm - View Document

Microsoft Word - workshop Hausman - ethics and economics of health care.docx

DocID: 1uV5k - View Document